Statistics Collaborative - Design and analysis for biomedical research


Aparna Anderson

  • Shen Y, Anderson AB, Sinha R, Li Y. Joint Modeling Tumor Burden and Time to Event Data in Oncology Trials. Pharmaceutical Statistics 2014, 13:286-293.

  • Averbuch SD, Anderson AB, Boerner SA, LoRusso PM. Making the Investigational Oncology Pipeline More Efficient and Effective: Are We Headed in the Right Direction? Cancer Clinical Research 2010, 16:5956-5962.

  • Hoos A, Eggermont A, Janetzki S, Hodi FS, Ibrahim R, Anderson A, Humphrey R, Blumenstein B, Old L, Wolchok J. Improved Endpoints for Cancer Immunotherapy Trials. Journal of the National Cancer Institute 2010, 102:1388-1397.

  • Chen T, Anderson A. Novel Cancer Therapies: Issues to Consider in Designing Clinical Trials. Biopharmaceutical Report 2009, 16:4-10.

  • Boergerhoff LA, Gerberich SG, Anderson A, Kochevar L, Waller L. Out-of-hospital violence injury surveillance: quality of data collection. Annals of Emergency Medicine 1999, 34:745-750.

  • Lee SS, Gerberich SG, Waller LA, Anderson A, McGovern P. Work-related assault among nurses. Epidemiology 1999, 10:685-691.

  • Anderson A, Prentice R. On the accommodation of disease rate correlations in aggregate data studies of disease risk factors. Biometrics 1998, 54:1527-1540.